NLMSF Accountability Reports
Annual Reports on Our Mission, Impact & Financial Stewardship
Explore our comprehensive annual accountability reports that detail our research funding commitments, grant awards, patient support initiatives, and community impact. Each report provides transparent insights into how we're advancing leiomyosarcoma (LMS) research and supporting patients and their families.
Our Commitment to Transparency
The National Leiomyosarcoma Foundation is committed to full transparency in our operations, funding decisions, and impact measurement.
Financial Transparency
Detailed breakdowns of our funding allocations, research investments, and operational expenses.
Research Impact
Comprehensive reporting on funded research projects, outcomes, and scientific breakthroughs.
Community Support
Detailed accounts of patient support programs, educational initiatives, and community outreach efforts.
Partnership Impact
Reports on collaborations with healthcare institutions, research organizations, and community partners.
Annual Accountability Reports
Access our comprehensive annual reports documenting our progress, achievements, and financial stewardship.
2024 Accountability Report
Our comprehensive 25th anniversary report detailing research funding, grant awards, repurposed drug initiatives, and expanded international collaborations.
2023 Accountability Report
Our annual report highlighting achievements in leiomyosarcoma research, patient support programs, and community advocacy initiatives.
2025 Accountability Report
Our upcoming report will detail continued progress in research funding, expanded patient support programs, and new partnership initiatives.
Expected Publication: Q1 2026
2024 Foundation Impact
Questions About Our Reports?
We're committed to transparency and welcome your questions about our accountability reports.